| Overall (n = 22) | Control (n = 9) | D2M (n = 13) |  | |||
---|---|---|---|---|---|---|---|
Parameter | n | Summary | n | Summary | n | Summary | p-value |
Fasting glucose (mg/dl) | 22 | 147.0 [91.0,198.0] | 9 | 90.0 [83.0,93.0] | 13 | 180.0 [161.0,240.0] | < 0.001 b |
BMI (kg/m2) | 22 | 31.9 [26.4,37.0] | 9 | 25.6 [21.2,26.9] | 13 | 36.5 [33.4,37.5] | < 0.001 b |
HDL-cholesterol (mg/dl) | 22 | 44.5 [37.0,56.0] | 9 | 63.0 [45.0,72.0] | 13 | 41.0 [37.0,45.0] | 0.005 b |
Triglycerides (mg/dl) | 22 | 141.5 [82.0,187.0] | 9 | 74.0 [50.0,86.0] | 13 | 174.0 [152.0,337.0] | 0.008 b |
HOMA | 22 | 4.8 [1.3,14.8] | 9 | 1.2 [1.1,1.5] | 13 | 14.4 [6.8,22.0] | < 0.001 b |
Total cholesterol (mg/dl) | 22 | 180.0 [158.0,202.0] | 9 | 175.0 [143.0,195.0] | 13 | 187.0 [172.0,202.0] | 0.32b |
LDL-cholesterol (mg/dl) | 21 | 95.0 [79.0,109.0] | 8 | 85.0 [65.5,95.5] | 13 | 104.0 [82.0,114.0] | 0.15b |
Fasting insulin (mU/l) | 22 | 10.6 [6.3,34.3] | 9 | 5.9 [5.4,7.1] | 13 | 32.4 [16.9,41.5] | <0.001 b |
Age (years) | 22 | 49.0 [41.7,55.6] | 9 | 46.0 [30.0,57.2] | 13 | 51.1 [43.7,55.3] | 0.37b |
Female | 22 | 15 (68.2) | 9 | 7 (77.8) | 13 | 8 (61.5) | 0.65d |
Systolic blood pressure (mmHG) | 22 | 126.0 [115.0,138.0] | 9 | 108.0 [104.0,115.0] | 13 | 137.0 [133.0,156.0] | < 0.001 b |
Diastolic blood pressure (mmHG) | 22 | 76.0 [68.0,89.0] | 9 | 66.0 [65.0,69.0] | 13 | 89.0 [83.0,91.0] | < 0.001 b |
MPO activity (mOD/μL/min) | 21 | 8.3 [5.1,14.8] | 9 | 11.8 [4.4,14.6] | 12 | 6.5 [5.6,20.9] | 0.31b |
pHDL assay (RFU mg HDLc/min) | 21 | 0.42 [0.28,0.50] | 9 | 0.26 [0.25,0.34] | 12 | 0.49 [0.42,0.54] | < 0.001 b |
Cp activity (μmol.min-1/mL) | 21 | 0.16 [0.14,0.18] | 9 | 0.18 [0.14,0.25] | 12 | 0.16 [0.14,0.17] | 0.22b |
PONI1 activity (nmole.min-1/μL) | 21 | 0.01 [0.01,0.01] | 9 | 0.01 [0.01,0.01] | 12 | 0.01 [0.01,0.01] | 0.15b |
apoA-1 (mg/dl) | 20 | 128.6 [114.8,143.7] | 9 | 144.2 [129.4,174.5] | 11 | 124.5 [111.4,128.7] | 0.013 b |